PL
Pushp Lata Srivastava
About Pushp Lata Srivastava
Data last updated:
Pushp Lata Srivastava is a Director at Pamasha Pharmaceuticals Private Limited (since 2022) and Director at Pamasha Internet Private Limited (since 2021). The companies operate in Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹11.3 Lakh; the largest is Pamasha Pharmaceuticals Private Limited at ₹10.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 May 2022 | 2022 | ₹10.2 Lakh (FY 2025) | Active | |
| Director | 08 May 2021 | 2018 | ₹1.1 Lakh (FY 2025) | Active |
Board colleagues of Pushp Lata Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Srivastava | 09494889 | Pamasha Pharmaceuticals Private Limited , Pamasha Internet Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pushp Lata Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pushp Lata Srivastava
Pushp Lata Srivastava currently holds 2 directorships: Pamasha Pharmaceuticals Private Limited (Director, since 25 May 2022, revenue ₹10.2 Lakh (FY 2025)); Pamasha Internet Private Limited (Director, since 08 May 2021, revenue ₹1.1 Lakh (FY 2025)).
Pushp Lata Srivastava was first appointed on 08 May 2021 as Director at Pamasha Internet Private Limited. The most recent appointment on record is 25 May 2022 at Pamasha Pharmaceuticals Private Limited.
The 2 current companies of Pushp Lata Srivastava that report revenue have a combined latest revenue of ₹11.3 Lakh: Pamasha Pharmaceuticals Private Limited ₹10.2 Lakh (FY 2025); Pamasha Internet Private Limited ₹1.1 Lakh (FY 2025).
The current boards of Pushp Lata Srivastava's companies include Amit Kumar Srivastava (Pamasha Pharmaceuticals Private Limited).